,67 Analogous to observations in ovarian cancer, the role of MSLN as a prognostic marker in gastric cancer remains incompletely elucidated, warranting more studies to verify its clinical utility in this malignancy. This evidence concerns the gene MSLN and ovarian carcinoma.